- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Rajasthan Health Dept debunks cough syrup death rumours

In a much-needed clarification, the Rajasthan Health Department has confirmed that the tragic deaths of two children in Bharatpur and Sikar districts were not caused by the cough syrup distributed under the state's free medicine scheme.
In a statement released, Public Health Director Ravi Prakash Sharma revealed that investigations found that in both cases, the children had taken the syrup at home without a doctor's advice. He clarified that Dextromethorphan (DXM) drug is not prescribed to children as per protocol.
Health Minister Gajendra Singh had earlier ordered a probe into the matter after reports of poor-quality cough syrup surfaced.
Following the order, the Rajasthan Medical Services Corporation Limited (RMSCL) halted the supply and use of the drug, formed a three-member inquiry committee that includes its executive directors for quality control and logistics, along with the nodal officer of the chief minister’s free medicine scheme and sent some samples for testing at the state drug laboratory.
RMSCL has also ordered a ban on 19 other batches of the same drug supplied by the concerned manufacturer. Every drug batch supplied is first tested in approved laboratories, and only medicines meeting prescribed standards are released for hospital use. If any batch fails, it is barred from distribution. In cases where complaints are received, drugs are retested at the State Drug Testing Laboratory to ensure public safety.
However, in another case from Sikar, a child was wrongly prescribed a cough syrup containing the drug DXM. Subsequently, the Health Department initiated suspension proceedings against the doctor and pharmacist concerned for violating protocol.
The department has also issued an advisory directing doctors to strictly follow prescription protocols and ensure medicines are dispensed only against prescriptions. It also urged the public not to take medicines without medical advice.
Earlier reports by Medical Dialogues highlighted that similar incidents also surfaced in Srimadhopur and Bharatpur. In Bharatpur, even a doctor who examined the children later experienced health complications after consuming the medicine.
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751